---
schema_version: "secwatch.filing_event.v1"
accession: "0001681622-24-000088"
form_type: "8-K"
ticker: "VREX"
cik: "0001681622"
company_name: "Varex Imaging Corp"
filed_at: "2024-11-19T23:59:59+00:00"
generated_at: "2026-05-29T22:32:04.901895+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Varex Q4 FY24 revenue $206M; GAAP EPS loss $1.22, non-GAAP EPS $0.19

## Summary
- GAAP net loss of $1.22 per diluted share; non-GAAP EPS of $0.19, down from $0.45 YoY.
- Total revenue $206M in Q4 FY24, down 10% YoY; full-year revenue $811M.
- Medical segment revenue $144M (-12% YoY); Industrial $61M (-4% YoY).
- Ended FY24 with $213M cash and marketable securities; operating cash flow $26M in Q4.
- Q1 FY25 guidance: revenue $195-215M, non-GAAP EPS -$0.05 to $0.10.

## SEC filing metadata
- accession: 0001681622-24-000088
- form_type: 8-K
- ticker: VREX
- cik: 0001681622
- company_name: Varex Imaging Corp
- filed_at: 2024-11-19T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681622/000168162224000088/0001681622-24-000088-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681622/000168162224000088/vrex-20241119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001681622-24-000088
- JSON: https://secwatch.observer/filing/0001681622-24-000088.json
- Plain text: https://secwatch.observer/filing/0001681622-24-000088.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.